Inhibition of effector T lymphocytes mediated through antagonism of IL-4.
Richard
R
Enelow
Dawn F
DF
Baramki
Larry C
LC
Borish
D017209:Apoptosis; D002454:Cell Differentiation; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D066298:In Vitro Techniques; D015847:Interleukin-4 / Q000037:antagonists & inhibitors*; D008213:Lymphocyte Activation; D019948:Receptors, Interleukin-4 / Q000378:metabolism; D012995:Solubility; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D018417:Th1 Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D018418:Th2 Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology
D016207:Cytokines; D019948:Receptors, Interleukin-4; D015847:Interleukin-4